Besides evidence of GSK3β important regulatory effects in neuronal survival, increasing reports suggest its involvement in the pathophysiological mechanisms of depression, as GSK3β inhibitors have anti-depressant effects and ameliorate depressive-like behavior in animal models (Kaidanovich-Beilin et al., 2004). The gene discussed is GSK3B; the disease is major depressive disorder.